🕵️ ATYR Pharma Inc ($ATYR)
SEC insider & ownership activity, last 12 months · CIK 1339970 · every row links its SEC filing
Over the last 12 months insiders sold $6K against $961K of open-market buying. Schimmel Paul bought $961K in discretionary trades (Oct–May). 3 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Jun 3, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $961K (3 lots) · 3 sellers, $6K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Schimmel Paul | 3 | $961K | 0 | – | May 27, 2026 |
| Shukla Sanjay | 0 | – | 1 | $4K | Feb 4, 2026 |
| Broadfoot Jill Marie | 0 | – | 1 | $2K | Feb 4, 2026 |
| Denyes Nancy | 0 | – | 1 | $1K | Feb 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 8.7% | 13G | Jul 8, 2026 | filing ↗ | |
| Voting Shares Irrevocable Trust | 8.7% | 13G | Jul 8, 2026 | filing ↗ | |
| Thomas R. Donahue | 8.7% | 13G | Jul 8, 2026 | filing ↗ | |
| Ann C. Donahue | 8.7% | 13G | Jul 8, 2026 | filing ↗ | |
| J. Christopher Donahue | 8.7% | 13G | Jul 8, 2026 | filing ↗ | |
| FMR LLC | 6.1% | 13G | Jun 5, 2026 | filing ↗ | |
| Abigail P. Johnson | 6.1% | 13G | Jun 5, 2026 | filing ↗ | |
| Blackrock, Inc. | exited | 13G | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 11, 2026 | filing ↗ |
| Other events (8.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Delisting notice (3.01) | Dec 4, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Sep 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 15, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |
| Impairment (2.06) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |